Delivery Order SPE2DB22D3501-SPE2DB26FTE94
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on August 28, 2025, from the Defense Logistics Agency's Medical Supply Chain for Candesartan Cilexetil 8 mg tablets (90-count). The contract is valued at $2,152.03 and is classified as a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. This non-set-aside award was competitively awarded and represents a child contract...
- AmerisourceBergen Drug Corp was awarded a $2,385.30 delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 11, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count units) with a ceiling value of $59,408.56. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for Candesartan Cilexetil 16 mg tablets (90-count supply) with a ceiling value of $2,106.86. This competitively awarded, firm fixed-price delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, an approximately $1 billion vehicle running through December 2026. The contract involves no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) valued at $16,287.78. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price delivery order contract type with no set-aside designation. Performance will take place at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $3,201.64 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count) on October 21, 2025, with completion scheduled for October 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Candesartan Cilexetil 32 mg tablets in a quantity of 90 units, with a ceiling value of $4,775.40. This is a firm fixed price delivery order with an ultimate completion date of October 23, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Candesartan Cilexetil 4 mg tablets (90-count) with a ceiling value of $1,171.70. This competitive, non-set-aside delivery order represents a firm fixed-price transaction with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) with a ceiling value of $10,879.54. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units, with a contract ceiling value of $6,090.09. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through an open process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTE94Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 22, 2025, for Candesartan Cilexetil 16 mg tablets (90 count) with a ceiling value of $1,727.22. This competitive, firm fixed-price award carries an ultimate completion date of October 23, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. No set-aside designation was used for this award. The delivery order fulfills pharmaceutical supply requirements for the Department of Defense medical supply chain, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. This contract exemplifies the company's extensive portfolio supplying critical medications to military and veteran healthcare systems. The underlying SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/22/25 |